GRI Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-13.04	-3.22	-9.3	-4.82	-3.46	-4.31
Depreciation & Amortization	0	0	0.07	0.07	0.02	0
Share-Based Compensation	0.39	0.03	0.63	0.15	0.08	0.05
Other Operating Activities	3.66	2.1	0.29	0.89	0.48	1.89
Operating Cash Flow	-8.99	-1.09	-8.31	-3.71	-2.88	-2.37
Capital Expenditures	-0.01	-0	0	-0	0	-0
Change in Investments	0	0	-3.84	0	0	0
Investing Cash Flow	-0.01	-0	-3.84	-0	0	-0
Share Issuance / Repurchase	12.25	-0.12	15.5	0	4.98	2.99
Debt Issued / Paid	1.1	1.24	0.24	-0	1.11	0
Other Financing Activities	-2.55	-0.11	-	-	-	-
Financing Cash Flow	10.8	1.01	15.75	-0	6.09	2.99
Net Cash Flow	1.8	-0.08	3.59	-3.71	3.21	0.61
Free Cash Flow	-9	-1.09	-8.31	-3.71	-2.88	-2.37
Free Cash Flow Margin	-	-	-	-3708.00%	-	-
Free Cash Flow Per Share	-19.50	-8.44	-266.86	-172.80	-170.59	-311.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).